A clinical study for evaluating the utility and safety of robot-assisted aortic lymphadenectomy using da Vinci Si surgical system

A clinical study for evaluating the utility and safety of robot-assisted aortic lymphadenectomy using da Vinci Si surgical system - A clinical study for evaluating the utility and safety of robot-assisted aortic lymphadenectomy

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000020153

Enrollment

Registered

2015-12-10

Start date

2015-12-10

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

endometrial cancer

Interventions

Robot-assisted hysterectomy and pelvic and aortic lymphadenectomy for endometrial cancer

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Endometrial cancer FIGO stage IA-IIIC2

Exclusion criteria

Exclusion criteria: Patients who are not recommended for laparoscopic surgery or study enrollment because of complications and other factors

Design outcomes

Primary

Measure	Time frame
Anesthesia time, operative time, blood loss, intraoperative and postoperative complications, postoperative pain and hospital stay	—

Secondary

Measure	Time frame
Number of removed lymph nodes, postoperative levels of hemoglobin (Hb), white blood cells (WBC) and C-reactive protein (CRP), and fever	—

Countries

Japan

Contacts

Public ContactHiroyuki Ochi

University of Tsukuba Department of Obstetrics and Gynecology, Faculty of Medicine

hochi@md.tsukuba.ac.jp029-853-3073

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026